Condensed Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 6,379,977	$ 2,329,218
Inventory	412,038
Prepaid expenses	800,777	759,292
Deferred financing costs		408,000
Other current assets	14,638	20,188
Total current assets	7,607,430	3,516,698
Property and equipment, net	202,097	214,578
Other assets:
Goodwill	7,647,267	7,647,267
Other non-current assets	215,302	245,683
Total assets	15,672,096	11,624,226
Current liabilities:
Accounts payable	1,602,316	3,813,280
Accrued expenses	4,316,305	3,657,394
Deferred collaboration funding, current	2,890,097	8,412,971
Other current liabilities	742,323	741,425
Convertible note payable, current, at fair value	11,392,167
SWK Loans payable, current, at fair value	17,057,110	2,326,630
Total current liabilities	38,000,318	18,951,700
Deferred collaboration funding, non-current	3,661,868
SWK Loans payable, non-current, at fair value		3,240,601
Convertible note payable, at fair value		6,047,532
Other non-current liabilities	123,509	145,665
Total liabilities	41,785,695	28,385,498
Commitments and Contingencies (Note 8)
Stockholders’ deficit:
Preferred stock, $0.0001 par value; authorized 10,000,000 shares; none issued and outstanding
Common stock, $0.0001 par value; authorized 150,000,000 shares; 16,373,611 and 14,310,244 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively	2,342	1,962
Additional paid-in capital	130,912,034	123,984,035
Accumulated deficit	(157,027,975)	(140,747,269)
Total stockholders’ deficit	(26,113,599)	(16,761,272)
Total liabilities and stockholders’ deficit	$ 15,672,096	$ 11,624,226